ArticleAnnals of hematology2025

Imatinib and blinatumomab successfully rescued a pediatric B-ALL patient with TERF2::PDGFRB fusion resistant to dasatinib and chemotherapy.

Fanghua Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.